Genpact (NYSE: G) furnishes press release on Q4 and 2025 financial results

Rhea-AI Filing Summary

Genpact Limited furnished a Form 8-K to provide a press release announcing its financial results for the three months and full year ended December 31, 2025. The press release is included as Exhibit 99.1 and is incorporated by reference.

The company notes that the press release and related conference call include non-GAAP financial measures, and that reconciliations to the most directly comparable GAAP figures are provided in the press release. The information under Item 2.02 is furnished, not filed, so it is not subject to certain Exchange Act liabilities or automatically incorporated into other SEC filings.

0001398659FALSE00013986592026-02-052026-02-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 5, 2026

GENPACT LIMITED

(Exact name of registrant as specified in its charter)

Bermuda			001-33626			98-0533350
(State or other jurisdiction of incorporation)			(Commission      File Number)			(I.R.S. Employer Identification No.)

Canon's Court, 22 Victoria Street

Hamilton HM 12, Bermuda

(Address of Principal Executive Offices) (Zip Code)

Registrant's telephone number, including area code: (441) 298-3300

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol			Name of each exchange on which registered
Common shares, par value $0.01 per share			G			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02Results of Operations and Financial Condition.

On February 5, 2026, Genpact Limited (the “Company”) issued a press release announcing its financial results for the three months and full year ended December 31, 2025.  The Company is furnishing this Form 8-K pursuant to Item 2.02, “Results of Operations and Financial Condition.” A copy of the press release, attached hereto as Exhibit 99.1, is incorporated herein by reference.

The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

The Company is making reference to non-GAAP financial information in the press release and on the conference call.  A reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures is contained in the attached press release.

Item 9.01.Financial Statements and Exhibits.

(d)Exhibits:

Exhibit 99.1						Press release dated February 5, 2026
Exhibit 104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

GENPACT LIMITED

Date: February 5, 2026

By:

/s/ Michael Weiner

Name:

Michael Weiner

Title:

Senior Vice President, Chief Financial Officer

FAQ

What did Genpact (G) announce in this Form 8-K filing?

Genpact furnished a Form 8-K to share a press release announcing its financial results for the three months and full year ended December 31, 2025. The release is attached as Exhibit 99.1 and incorporated by reference.

Which period’s results does Genpact (G) cover in this 8-K?

The filing states that Genpact’s press release provides financial results for the three months and full year ended December 31, 2025. These quarterly and annual figures are detailed in Exhibit 99.1, which is attached to and incorporated into the Form 8-K.

How does Genpact (G) treat non-GAAP financial measures in this filing?

Genpact explains that the press release and conference call use non-GAAP financial information. It also states that a reconciliation of each non-GAAP measure to the most directly comparable GAAP financial measure is included in the attached press release, Exhibit 99.1.

Is the financial information in Genpact’s Form 8-K considered filed with the SEC?

The company specifies that the information in this report, including Exhibit 99.1, is being furnished under Item 2.02 and shall not be deemed filed for purposes of Section 18 of the Exchange Act, nor automatically incorporated into other Securities Act or Exchange Act filings.

What exhibits are included with Genpact’s February 5, 2026 Form 8-K?

The filing lists Exhibit 99.1 as a press release dated February 5, 2026, providing financial results. It also lists Exhibit 104 as the cover page interactive data file, which is embedded within the Inline XBRL version of the document for electronic reporting purposes.

Who signed Genpact’s Form 8-K reporting the 2025 results?

The Form 8-K was signed on behalf of Genpact Limited by Michael Weiner. He is identified in the document as the company’s Senior Vice President and Chief Financial Officer, acting as the duly authorized representative for this report.